Zobrazeno 1 - 8
of 8
pro vyhledávání: '"Joram, Siangla"'
Autor:
John N. Waitumbi, Moureen Maraka, Joram Siangla, Kariuki Njaanake, Benson B. Estambale, Beth Mutai, Clement Masakhwe, Allan Lemtudo, Josphat Nyataya, Nancy Nyakoe
Publikováno v:
Vector-Borne and Zoonotic Diseases. 20:348-357
Data on pathogen prevalence is crucial for informing exposure and disease risk. We evaluated serological evidence of tick-borne encephalitis (TBE), West Nile (WN), Hepatitis E virus (HEV), Crimean-Congo Hemorrhagic Fever (CCHF), Yersiniosis, Lyme Dis
Autor:
Bernhards R Ogutu, Odika J Apollo, Denise McKinney, Willis Okoth, Joram Siangla, Filip Dubovsky, Kathryn Tucker, John N Waitumbi, Carter Diggs, Janet Wittes, Elissa Malkin, Amanda Leach, Lorraine A Soisson, Jessica B Milman, Lucas Otieno, Carolyn A Holland, Mark Polhemus, Shon A Remich, Christian F Ockenhouse, Joe Cohen, W Ripley Ballou, Samuel K Martin, Evelina Angov, V Ann Stewart, Jeffrey A Lyon, D Gray Heppner, Mark R Withers, MSP-1 Malaria Vaccine Working Group
Publikováno v:
PLoS ONE, Vol 4, Iss 3, p e4708 (2009)
The antigen, falciparum malaria protein 1 (FMP1), represents the 42-kDa C-terminal fragment of merozoite surface protein-1 (MSP-1) of the 3D7 clone of P. falciparum. Formulated with AS02 (a proprietary Adjuvant System), it constitutes the FMP1/AS02 c
Externí odkaz:
https://doaj.org/article/656dad9481c241c485519a092be610e9
Autor:
Mitra Singhal, Joseph N. Koros, Jay Gerlach, Samuel B. Anyona, Matt Steele, John N. Waitumbi, Kate Watts, Nicolaas M. J. Vermeulen, Mark E. Polhemus, Irina Ankoudinova, Walt Mahoney, Joram Siangla, Irina A. Afonina, Gonzalo J. Domingo
Publikováno v:
Tropical Medicine & International Health. 16:786-793
Summary objectives To determine the malaria prevalence by microscopy, antigen detection and nucleic acid detection in a defined subpopulation in a Plasmodium falciparum–endemic region during the peak transmission season. methods Blood specimens wer
Autor:
Michael J. Walter, Kent E. Kester, Nadia Tornieporth, Carl J. Mason, D. Gray Heppner, Malachi O. Opollo, Joram Siangla, Laurence Vigneron, Gerald Voss, José A. Stoute, Joe Cohen, W. Ripley Ballou
Publikováno v:
The American Journal of Tropical Medicine and Hygiene. 75:166-170
We conducted a phase 1 trial of candidate malaria vaccine RTS,S/AS02A in western Kenya to determine its safety and immunogenicity in healthy adults in an area hyperendemic for malaria. Twenty adults were enrolled and received RTS,S/AS02A (50 microg o
Autor:
Kingsley Badu, Franck Remoue, Guofa Zhou, John M. Ong’echa, Guiyun Yan, Bernard W. Lawson, Andrew K. Githeko, John A. Larbi, Yaw A. Afrane, Joram Siangla
Publikováno v:
Badu, Kingsley; Siangla, Joram; Larbi, John; Lawson, Bernard W; Afrane, Yaw; Ong’echa, John; et al.(2012). Variation in exposure to Anopheles gambiae salivary gland peptide (gSG6-P1) across different malaria transmission settings in the western Kenya highlands. Malaria Journal, 11(1), 318. doi: http://dx.doi.org/10.1186/1475-2875-11-318. Retrieved from: http://www.escholarship.org/uc/item/4362m53v
Malaria Journal, Vol 11, Iss 1, p 318 (2012)
Malaria Journal
Malaria Journal, Vol 11, Iss 1, p 318 (2012)
Malaria Journal
Background The existing metrics of malaria transmission are limited in sensitivity under low transmission intensity. Robust surveillance systems are needed as interventions to monitor reduced transmission and prevention of rapid reintroduction. Serol
Autor:
John N, Waitumbi, Jay, Gerlach, Irina, Afonina, Samuel B, Anyona, Joseph N, Koros, Joram, Siangla, Irina, Ankoudinova, Mitra, Singhal, Kate, Watts, Mark E, Polhemus, Nicolaas M, Vermeulen, Walt, Mahoney, Matt, Steele, Gonzalo J, Domingo
Publikováno v:
Tropical medicineinternational health : TMIH. 16(7)
To determine the malaria prevalence by microscopy, antigen detection and nucleic acid detection in a defined subpopulation in a Plasmodium falciparum-endemic region during the peak transmission season.Blood specimens were collected in a cross-section
Autor:
Bernhards R, Ogutu, Odika J, Apollo, Denise, McKinney, Willis, Okoth, Joram, Siangla, Filip, Dubovsky, Kathryn, Tucker, John N, Waitumbi, Carter, Diggs, Janet, Wittes, Elissa, Malkin, Amanda, Leach, Lorraine A, Soisson, Jessica B, Milman, Lucas, Otieno, Carolyn A, Holland, Mark, Polhemus, Shon A, Remich, Christian F, Ockenhouse, Joe, Cohen, W Ripley, Ballou, Samuel K, Martin, Evelina, Angov, V Ann, Stewart, Jeffrey A, Lyon, D Gray, Heppner, Mark R, Withers, Mark, Fukuda
Publikováno v:
PLoS ONE
PLoS ONE, Vol 4, Iss 3, p e4708 (2009)
PLoS ONE, Vol 4, Iss 3, p e4708 (2009)
Objective The antigen, falciparum malaria protein 1 (FMP1), represents the 42-kDa C-terminal fragment of merozoite surface protein-1 (MSP-1) of the 3D7 clone of P. falciparum. Formulated with AS02 (a proprietary Adjuvant System), it constitutes the F
Autor:
José A, Stoute, D Gray, Heppner, Carl J, Mason, Joram, Siangla, Malachi O, Opollo, Kent E, Kester, Laurence, Vigneron, Gerald, Voss, Michael J, Walter, Nadia, Tornieporth, Joe D, Cohen, W Ripley, Ballou
Publikováno v:
The American journal of tropical medicine and hygiene. 75(1)
We conducted a phase 1 trial of candidate malaria vaccine RTS,S/AS02A in western Kenya to determine its safety and immunogenicity in healthy adults in an area hyperendemic for malaria. Twenty adults were enrolled and received RTS,S/AS02A (50 microg o